Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults

Autor:	Laurence L, Greenhill, Steven, Pliszka, Mina K, Dulcan, William, Bernet, Valerie, Arnold, Joseph, Beitchman, R Scott, Benson, Oscar, Bukstein, Joan, Kinlan, Jon, McClellan, David, Rue, Jon A, Shaw, Saundra, Stock
Rok vydání:	2002
Předmět:	Adult medicine.medical_specialty Adolescent Psychopharmacology medicine.medical_treatment Pemoline Developmental and Educational Psychology medicine Humans Attention deficit hyperactivity disorder Child Psychiatry Amphetamine Narcolepsy Psychotropic Drugs Evidence-Based Medicine Methylphenidate Contraindications Amphetamines Dextroamphetamine Brain Evidence-based medicine medicine.disease United States Stimulant Psychiatry and Mental health Attention Deficit Disorder with Hyperactivity Child Preschool Central Nervous System Stimulants Drug Monitoring Psychology medicine.drug
Zdroj:	Journal of the American Academy of Child & Adolescent Psychiatry. 41:26S-49S
ISSN:	0890-8567
DOI:	10.1097/00004583-200202001-00003
Popis:	This practice parameter describes treatment with stimulant medication. It uses an evidence-based medicine approach derived from a detailed literature review and expert consultation. Stimulant medications in clinical use include methylphenidate, dextroamphetamine, mixed-salts amphetamine, and pemoline. It carries FDA indications for treatment of attention-deficit/hyperactivity disorder and narcolepsy.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::300747edb2bd5437ea5fa40ef0cca865 https://doi.org/10.1097/00004583-200202001-00003 Zobrazit plný text záznamu